Stock 4887 SAWAI GROUP HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sawai Group Holdings Co., Ltd.

Equities

4887

JP3323040000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 11:30:00 20/05/2024 am IST 		5-day change 1st Jan Change
6,105 JPY -0.63% Intraday chart for Sawai Group Holdings Co., Ltd. +8.15% +17.20%
03/04 Sawai Group Finalizes Sale of US Subsidiary MT
01/04 Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. CI

Business Summary

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

Number of employees: 3,393

Sales per Business

JPY in Million2022Weight2023Weight Delta
Circulatory Organ Drug
24.5 %
51,415 26.5 % 49,135 24.5 % -4.43%
Central Nervous System Drug
21.0 %
35,357 18.2 % 42,147 21.0 % +19.20%
Others
9.7 %
18,525 9.6 % 19,520 9.7 % +5.37%
Digestive Medicine
9.2 %
19,004 9.8 % 18,357 9.2 % -3.40%
Blood - Fluid Drug
8.2 %
17,050 8.8 % 16,448 8.2 % -3.53%
Other Metabolic Drugs
7.9 %
13,622 7.0 % 15,827 7.9 % +16.19%
Antibiotic Preparation
4.0 %
7,329 3.8 % 8,033 4.0 % +9.61%
Vitamin Preparation
3.7 %
8,851 4.6 % 7,426 3.7 % -16.10%
Allergy Medication
3.3 %
6,884 3.6 % 6,522 3.3 % -5.26%
Urogenital Organ and Anus Medicine
3.0 %
5,670 2.9 % 6,033 3.0 % +6.40%
Drug for Tumor
2.8 %
5,033 2.6 % 5,662 2.8 % +12.50%
Respiratory Medicine
2.6 %
5,076 2.6 % 5,236 2.6 % +3.15%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
81.7 %
163,841 84.5 % 163,702 81.7 % -0.08%
United States
18.3 %
29,975 15.5 % 36,642 18.3 % +22.24%

Managers

Managers TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 01/21/01
Kazuhiko Sueyoshi PSD
 President 66 01/21/01
Toru Terashima BRD
 Director/Board Member 64 01/21/01
Kenzo Sawai BRD
 Director/Board Member 56 01/21/01
Tadao Tsubokura AUD
 Comptroller/Controller/Auditor 63 01/21/01
Taku Nakaoka PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 01/21/01
Kenzo Sawai BRD
 Director/Board Member 56 01/21/01
Masatoshi Ohara BRD
 Director/Board Member 73 01/21/01
Kazuhiko Sueyoshi PSD
 President 66 01/21/01
Nawomi Todo BRD
 Director/Board Member 64 01/21/01
Toru Terashima BRD
 Director/Board Member 64 01/21/01

Shareholders

NameEquities%Valuation
Silchester International Investors LLP
8.839 %
3,871,600 8.839 % 145 M ¥
Nomura Asset Management Co., Ltd.
6.287 %
2,754,100 6.287 % 103 M ¥
JPMorgan Asset Management (Japan) Ltd.
3.560 %
1,559,400 3.560 % 58 M ¥
JPMorgan Asset Management (Asia Pacific) Ltd.
2.992 %
1,310,700 2.992 % 49 M ¥
Mitsuo Sawai
2.413 %
1,057,000 2.413 % 40 M ¥
Sawai Hiroyuki Family
2.269 %
994,000 2.269 % 37 M ¥
Kenzo Sawai
1.950 %
854,000 1.950 % 32 M ¥
Nikko Asset Management Co., Ltd.
1.655 %
725,000 1.655 % 27 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
1.484 %
650,000 1.484 % 24 M ¥
Sawai Mitsuo KK
1.472 %
645,000 1.472 % 24 M ¥

Holdings

NameEquities%Valuation
SUMITOMO CORPORATION
0.07%
 858,000 0.07% 22,654,272 $
NIPPON KAYAKU CO., LTD.
0.51%
 875,000 0.51% 7,150,570 $
MEDIPAL HOLDINGS CORPORATION
0.10%
 218,100 0.10% 3,423,295 $
ALFRESA HOLDINGS CORPORATION
0.11%
 224,000 0.11% 3,325,161 $
YAKULT HONSHA CO.,LTD.
0.04%
 148,800 0.04% 2,918,036 $
MEDICAL IKKOU GROUP CO.,LTD.
3.44%
 140,000 3.44% 2,272,169 $
DAITO PHARMACEUTICAL CO.,LTD.
0.62%
 96,800 0.62% 1,553,204 $
ASAHI PRINTING CO.,LTD.
0.71%
 165,200 0.71% 962,657 $
SUSMED,INC.
1.46%
 245,000 1.46% 848,506 $
TECHNO RYOWA LTD.
0.14%
 31,460 0.14% 383,841 $

Company contact information

SAWAI GROUP HOLDINGS Co., Ltd.

5-2-30 Miyahara Yodogawa-Ku

532-0003, Osaka

+

http://www.sawaigroup.holdings
address Sawai Group Holdings Co., Ltd.(4887)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Sawai Group Holdings Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
6,144 JPY
Average target price
6,980 JPY
Spread / Average Target
+13.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SAWAI GROUP HOLDINGS CO., LTD. Stock Sawai Group Holdings Co., Ltd.
+17.20% 173.14Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.83% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 58TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.28% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+7.19% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.83% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+8.79% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4887 Stock
  4. Company Sawai Group Holdings Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW